Clinical Trials Search Results - University of Colorado Hospital

Skip to Content

Cancer

Search for

in

In Progress (5)

Showing 1-5 of 5

Sorted By:

A-Z
Z-A

A Phase Ib, Open label, Dose-Escalation Study evaluating the Safety, Tolerability and Pharmacokinetics of RO5185426 in Combination with GDC-0973 when Administered in Patients with BRAFV600E-Positive Metastatic Melanoma who have Progressed after treatment with RO5185426
An Open-Label, 2-Cohort, Multicenter, Phase 2 Study of E7080 in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma
ECOG E1609; A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a2b for Resected High Risk Melanoma
GSKBRF 113220: An Open-Label, Dose-Escalation, Phase I/II Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the BRAF Inhibitor GSK2118436 in Combination with the MEK Inhibitor GSK1120212 in Subjects with BRAF Mutant Metastatic Melanoma
Phase II study of marqibo in patients with metastatic uveal melanoma

Showing trials 1-5 of 5